638 related articles for article (PubMed ID: 19041358)
1. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
Xie Y; Sun HX; Li D
Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358
[TBL] [Abstract][Full Text] [Related]
2. Platycodin D2 improves specific cellular and humoral responses to hepatitis B surface antigen in mice.
Xie Y; He SW; Sun HX; Li D
Chem Biodivers; 2010 Jan; 7(1):178-85. PubMed ID: 20087984
[TBL] [Abstract][Full Text] [Related]
3. Screening and appraisal for immunological adjuvant-active fractions from Platycodon grandiflorum total saponins.
Ouyang K; Chen L; Sun H; Du J; Shi M
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):126-34. PubMed ID: 21682667
[TBL] [Abstract][Full Text] [Related]
4. RLJ-NE-299A: a new plant based vaccine adjuvant.
Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
[TBL] [Abstract][Full Text] [Related]
5. Platycodin d improves the immunogenicity of newcastle disease virus-based recombinant avian influenza vaccine in mice.
Xie Y; Sun HX; Li D
Chem Biodivers; 2010 Mar; 7(3):677-89. PubMed ID: 20232336
[TBL] [Abstract][Full Text] [Related]
6. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the glycidic moieties to the haemolytic and adjuvant activity of platycodigenin-type saponins from the root of Platycodon grandiflorum.
Xie Y; Ye YP; Sun HX; Li D
Vaccine; 2008 Jun; 26(27-28):3452-60. PubMed ID: 18501482
[TBL] [Abstract][Full Text] [Related]
8. Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses.
Xie Y; Deng W; Sun H; Li D
Int Immunopharmacol; 2008 Aug; 8(8):1143-50. PubMed ID: 18550019
[TBL] [Abstract][Full Text] [Related]
9. Structure-function relationship of the saponins from the roots of Platycodon grandiflorum for hemolytic and adjuvant activity.
Sun H; Chen L; Wang J; Wang K; Zhou J
Int Immunopharmacol; 2011 Dec; 11(12):2047-56. PubMed ID: 21945665
[TBL] [Abstract][Full Text] [Related]
10. Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity.
Sun HX; Wang H; Xu HS; Ni Y
Vaccine; 2009 Jun; 27(30):3984-91. PubMed ID: 19389450
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
[TBL] [Abstract][Full Text] [Related]
12. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL
FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224
[TBL] [Abstract][Full Text] [Related]
13. A promising balanced Th1 and Th2 directing immunological adjuvant, saponins from the root of Platycodon grandiflorum.
Xie Y; Pan H; Sun H; Li D
Vaccine; 2008 Jul; 26(31):3937-45. PubMed ID: 18547688
[TBL] [Abstract][Full Text] [Related]
14. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
[TBL] [Abstract][Full Text] [Related]
15. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine.
Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH
Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of hyaluronic acid-based combination adjuvant containing monophosphoryl lipid A and aluminum salt for hepatitis B vaccine.
Moon SH; Shin EC; Noh YW; Lim YT
Vaccine; 2015 Sep; 33(38):4762-9. PubMed ID: 26271830
[TBL] [Abstract][Full Text] [Related]
17. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg.
Khajuria A; Gupta A; Malik F; Singh S; Singh J; Gupta BD; Suri KA; Suden P; Srinivas VK; Ella K; Qazi GN
Vaccine; 2007 Jun; 25(23):4586-94. PubMed ID: 17498851
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant-active fraction from Albizia julibrissin saponins improves immune responses by inducing cytokine and chemokine at the site of injection.
Sun H; He S; Shi M
Int Immunopharmacol; 2014 Oct; 22(2):346-55. PubMed ID: 25075718
[TBL] [Abstract][Full Text] [Related]
19. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
[TBL] [Abstract][Full Text] [Related]
20. PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA.
Shen E; Li L; Li L; Feng L; Lu L; Yao Z; Lin H; Wu C
Cell Mol Immunol; 2007 Apr; 4(2):113-20. PubMed ID: 17484805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
